|
|
 |
|
Pharma companies are increasingly focusing on signal detection to improve drug safety. However, signal detection is not the goal - it is merely a component of a much larger process that ultimately leads to an enhanced benefit:risk profile. This webcast will discuss how a "structured" signal management approach facilitates pharma's risk management initiatives. The presentation will be lead by Sanket Agrawal, Chief Strategy Officer, and supported by Axel Hagel, VP of Drug Safety, and Muneet Burke, MD, Product Manager for Safety & Risk Management.
Agenda
- Pharmaceutical risk management: Business & Regulatory Drivers
- Overview of signal detection and decision management approaches
- Structured signal management: the holistic best practice
- Enabling SSM with Argus Perceptive & Insight
For further questions regarding this webcast or Relsys risk management solutions, please contact us at info@relsys.net or +1 949-453-1715.
About Relsys International
Relsys International provides the industry-leading Argus suite, a complete systems solution for Drug Safety, Pharmacovigilance and Risk Management that helps pharmaceutical, biotech and medical device companies improve drug safety and ensure ongoing compliance with global regulations. The company, founded in 1987, works in partnership with its customers to develop and deliver innovative solutions to long-term business needs, and to provide critical components to support its clients' corporate risk management strategies. Argus Safety™, the company's flagship product, is the world's widely-used drug safety and adverse event reporting software. Relsys is a privately held company, headquartered in Irvine, California. For more information, visit www.relsys.net, or call +1 949-453-1715.
|
|
